ReCode Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 28, 2020
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $80,000,000
Company Info
- Founders
- David Lockhart
- Company Description
- ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
- Market
- Genetic respiratory diseases
- Location
- Dallas, Texas, USA
- Coinvestors
- Colt Ventures, Hunt Technology Ventures, MPM Capital, OrbiMed Advisors, Osage University Partners, Vida Ventures